Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Toichi Takenaka) has today announced that Executive Vice President Masafumi Nogimori will be promoted to President and CEO of Astellas, Dr. Toichi Takenaka, now, President and CEO, will become Co-Chairman. Dr. Hatsuo Aoki, now Chairman, will also be Co-Chairman. These changes will take effect on the day of the ordinary general meeting of shareholders of the Company, which is planned on June 27, 2006, subject to the approval of the Board of Directors meeting to be held on the same day.

Dr. Takenaka, now sixty four years old, became President and CEO of then Yamanouchi Pharmaceutical Co., Ltd. in April 2000. He had enforced the restructuring of business operations in order to concentrate the management resources on the ethical pharmaceuticals business in the amidst of fierce global competition. Since its inception of April 2005, Astellas, under the direction of Dr. Takenaka, has taken a further step toward the concentration on the ethical pharmaceutical business and has also reinforced the business infrastructure of the Company through enrichment of its development pipeline and expansion of the US business. Dr. Takenaka has decided to designate Mr. Nogimori as his successor because he thinks Mr. Nogimori is the right person to strongly implement growth strategies of Astellas as a global pharmaceutical company.

Mr. Nogimori, fifty eight years old, is now Executive Vice President of the Company. Mr. Nogimori had been working for then Fujisawa Pharmaceutical Co., Ltd. for thirty six years since he joined Fujisawa in 1970. He experienced various careers in Fujisawa from licensing, business development, head of its European operations to Global Corporate Strategy. He became Executive Vice President of Astellas at the formation of the Company.

Curriculum Vitae

Name Masafumi Nogimori 
Date of Birth December 21, 1947 


March 1970 The University of Tokyo
Faculty of Pharmacy 

-Business Experience-

April 2005 Representative Director, Executive Vice President
Astellas Pharma Inc., Tokyo, Japan
(Yamanouchi and Fujisawa have been merged to become Astellas Pharma Inc., April 2005.)
June 2004 Corporate Executive Vice President,
Global Strategy  
June 2003 Member of the Board
Corporate Senior Vice President,
Global Strategy  
June 2001 Corporate Senior Vice President,
Global Corporate Strategic Planning
Fujisawa Pharmaceutical Co., Ltd.  
June 2000 Corporate Vice President,
Fujisawa Pharmaceutical Co., Ltd.  
July 1998 President,
Fujisawa GmbH
June 1997 Member of the Board
Executive Director,
Planning and Coordination Division, Ethical Pharmaceuticals
July 1995 Director, Planning & Coordination
Ethical Pharmaceuticals Division
April 1970 Staff Member, R&D Planning
Fujisawa Pharmaceutical Co., Ltd. 


Contact the Media Relations team
Communications & Investor Relations
Main phone line for Media: +81-3244-3201 
Business hours (JST)
From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm
(closed on Saturdays, Sundays, national holidays and company holidays)